Exelixis (NASDAQ:EXEL) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Analysts have recently evaluated Exelixis and provided 12-month price targets. The average target is $29.4, accompanied by a high estimate of $33.00 and a low estimate of $27.00. This upward trend is evident, with the current average reflecting a 2.08% increase from the previous average price target…